add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
Related: Results 41 - 50 for Amylin PharmaceuticalsAmylin Pharmaceuticals, Inc Q4 2008 Earnings Call Transcript ...Amylin Pharmaceuticals, Inc . Q4 2008 Earnings Call. January 27, 2009 5:00 pm ET. Executive s. Michael York - SD of IR. Daniel Bradbury - President and CEO http://seekingalpha.com/article/116891-amylin-pharmaceuticals-inc-q4-2008-earnings-call-transcript open pop Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging ... Findings Further Support Leptin as Part of Company s Integrated Neurohormonal Therapy for Obesity (INTO) Strategy Amylin Pharmaceuticals, Inc. (NASDAQ AMLN) tod http://www.drugs.com/clinical_trials/amylin-pharmaceuticals-announces-positive-results-ranging-clinical-study-pramlintid... open pop AMLN - Amylin Pharmaceuticals Inc Stock quote - CNNMoney.com Amylin Pharmaceuticals, Inc. is a biopharmaceutical company focusing on people with diabetes, obesity and other diseases through the discovery, development and commercialization of ... http://money.cnn.com/quote/quote.html?symb=AMLN open pop (AMLN) Amylin Pharmaceuticals’ Loss Narrows | Stock Blog Hub Amylin Pharmaceuticals (AMLN) reported a loss of 19 cents per share in the third quarter, which was narrower than the Zacks Consensus Estimate of a loss of 30 http://www.stockbloghub.com/2009/10/21/amln-amylin-pharmaceuticals-loss-narrows/18390 open pop Amylin Pharmaceuticals Announces Positive Results From Amylin Pharmaceuticals Announces Positive Results From Dose-Ranging Clinical Study Of Pramlintide/Metreleptin Combination Treatment For Obesity http://www.pharmaceuticalonline.com/article.mvc/Amylin-Pharmaceuticals-Announces-Positive-0001?VNETCOOKIE=NO open pop Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic ... SAN DIEGO, Calif., Oct. 19, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN - News) today announced that new data from its obesity program will be http://biz.yahoo.com/prnews/091019/la94787.html?.v=1 open pop Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co ... SAN DIEGO and OSAKA, Japan, Nov. 1, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN - News) and Takeda Pharmaceutical Company Limited (TSE: 4502 - News) http://biz.yahoo.com/prnews/091101/la02961.html?.v=1 open pop Amylin Pharmaceuticals Diabetes Drug Byetta® the Focus of California ... Moore Labriola LLP and The Schmidt Firm, LLP Represent Virgina Man Who Developed Pancreatitis; FDA Seeks More Stringent Warnings August 20, 2008 (San Diego, http://www.schmidtandclark.com/first-byetta-lawsuit-filed open pop Amylin Pharmaceuticals Announces Positive Results From Dose-Ranging ... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced positive results from a 28-week dose-ranging study of pramlintide/metreleptin, a combination treatment comprising pramlintide ... http://www.medicalnewstoday.com/articles/157025.php open pop Amylin Pharmaceuticals signs weight-loss drug deal with Takeda ... NEW YORK - Amylin Pharmaceuticals Inc ... Minnesota business by the numbers. See Minnesota's top earning companies, CEOs and non-profits http://www.startribune.com/business/68527562.html open pop |
| Translate into any language... | ↑ top of page ↑ | about thumbshots |
